hotspot -WSS

hotspot

author：hotspot 2025-09-27 13:04:21 - browse：2723

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： My daughter's legacy lives on through her writing, phage therapy

leisure time

Wikipedia

WSS

Supreme Court to hear if Covid misinformation is protected speech

Deposition: Sackler embraced plan to conceal OxyContin’s strength

As H5N1 spreads in cows, experts warn against drinking raw milk

Readers discuss the intersection of pregnancy and addiction

New report analyzes digital physical therapy solutions' effectiveness

Hottest summer in 2,000 years puts focus on extreme heat, health

leisure time

hotspot

hotspot

Continuity nursing helped my family in our darkest PICU moments

Galapagos to make CAR

Jerome Adams on the need for new antivirals for Covid

WuXi Biologics beefs up its lobbying operation

Supreme Court strikes down use of affirmative action

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

What does generative AI mean for health care? We asked experts

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

In age of alternative facts, a scholarly course on calling out crap

Ripples from Flovent's discontinuation is killing children with asthma

hotspot

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Hottest summer in 2,000 years puts focus on extreme heat, health

Curing rare childhood diseases will falter unless Congress steps up

My daughter's legacy lives on through her writing, phage therapy

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Abbott's new stent may help patients with peripheral artery disease

Wikipedia

leisure time

Wikipedia

hotspot